Repurposed Molecules: Can Existing Drugs Find New Roles in Neurological Diseases?

Modern drug development is a long, expensive, and uncertain process. For this reason, one increasingly important strategy in biomedical research is drug repurposing — investigating whether a molecule already known and safely used in one disease can also be effective in another.

The idea is scientifically attractive for several reasons. When a molecule has already been used clinically, many critical parameters are already known: safety profile, pharmacokinetics, dosing ranges, adverse effects, and drug interactions. This can shorten the path from laboratory findings to potential clinical applications, reduce development costs, and decrease some of the risks associated with entirely new compounds.

Drug repurposing has therefore become an important research field, especially in complex disorders such as neurodegenerative diseases, psychiatric disorders, and epilepsy, where novel therapeutic targets are still actively being explored.

One interesting candidate in this context is minocycline, a tetracycline derivative traditionally used as an antibiotic. Beyond its antimicrobial effects, minocycline has attracted scientific attention for its anti-inflammatory, anti-apoptotic, and neuroprotective properties. These characteristics raise the question of whether the molecule may have therapeutic potential in neurological disorders as well.

In our study, we investigated the possible repurposing of minocycline in epilepsy. The work focused on evaluating whether this well-known tetracycline derivative could modulate mechanisms underlying epileptic activity and neuronal injury. The broader aim was to contribute to the growing body of evidence exploring how existing molecules may be repositioned for neurological therapeutics.

Drug repurposing not only offers economic advantages; it also represents a different way of thinking about pharmacology. Sometimes, a molecule developed for one biological pathway may unexpectedly provide benefit in an entirely different clinical context. Exploring these overlaps may help accelerate future therapeutic discoveries.

“Effect of Minocycline on Seizure” Published in the CSIR-National Institute of Science Communication and Policy Research journal, Indian Journal of Experimental Biology.

Originally published at https://or.niscpr.res.in.

DOI: https://doi.org/10.56042/ijeb.v62i08.4555